The U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use alongside glucocorticoids in ...
The US Food and Drug Administration has approved crinecerfont for treating congenital CAH in combination with glucocorticoids ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback